arrow_back Back to App

Additional Funding for COVID-19 and Future Pandemic Preparedness

This act allocates $10 billion for the production and distribution of medical supplies, tests, and vaccines related to COVID-19. These funds aim to ensure the availability of essential medical materials for citizens and prepare the country for future health threats. After 2022, the funds can be used to respond to other serious public health emergencies.
Key points
Allocates $10 billion for purchasing and producing masks, tests, vaccines, and other medical equipment to combat COVID-19.
Funds can be used for building or upgrading factories that produce medical supplies.
After 2022, unused funds can be directed towards responding to other significant public health emergencies.
The President can delegate authority to manage these funds to the Secretary of Health and Human Services or other agencies.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_1720
Sponsor: Rep. Vargas, Juan [D-CA-51]
Process start date: 2021-03-09
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

COVID–19 Medical Production Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_1720.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-03-09.

What are the main provisions?

Key points include:

  • Allocates $10 billion for purchasing and producing masks, tests, vaccines, and other medical equipment to combat COVID-19.
  • Funds can be used for building or upgrading factories that produce medical supplies.
  • After 2022, unused funds can be directed towards responding to other significant public health emergencies.
  • The President can delegate authority to manage these funds to the Secretary of Health and Human Services or other agencies.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Vargas, Juan [D-CA-51].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Financial Services.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

CATEGORIES

Health Public Investments